462 125 mg (Emend 125 mg)
Generic Name: aprepitant
Pill with imprint 462 125 mg is Pink & White, Capsule-shape and has been identified as Emend 125 mg. It is supplied by Merck & Company Inc..
Emend is used in the treatment of nausea/vomiting, chemotherapy induced and belongs to the drug class NK1 receptor antagonists. There is no proven risk in humans during pregnancy. Emend 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 462 125 mg
Emend
- Generic Name
- aprepitant
- Imprint
- 462 125 mg
- Strength
- 125 mg
- Color
- Pink & White
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nk1 receptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck & Company Inc.
- National Drug Code (NDC)
- 00006-0462 (Discontinued)
- Inactive Ingredients
-
sucrose,
microcrystalline cellulose,
sodium lauryl sulfate,
titanium dioxide,
silicon dioxide,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about Emend (aprepitant)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 13 Reviews
- Generic Availability
- Drug class: NK1 receptor antagonists
Patient resources
- Drug Information
- Emend (Advanced Reading)
- Emend (Aprepitant Capsules)
- Emend (Aprepitant Oral Suspension)
- Other brands
- Cinvanti
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.